BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23311810)

  • 1. Multidisciplinary treatment of a patient with type 2 diabetes and morbid obesity, or perhaps already a surgical diabetology.
    Szcześniak G; Jaworska J; Jaworski T; Dziemidok P
    Ann Agric Environ Med; 2012; 19(4):798-801. PubMed ID: 23311810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical considerations for the management of residual diabetes following bariatric surgery.
    Kashyap SR; Schauer P
    Diabetes Obes Metab; 2012 Sep; 14(9):773-79. PubMed ID: 22288474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bariatric surgery in a patient with adipositas permagna and uncontrolled insulin resistance].
    Haak T; Horbach T
    Dtsch Med Wochenschr; 2012 May; 137(19):993-6. PubMed ID: 22549255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are we helping or harming our insulin-treated diabetic patients during ambulatory treatment?
    Szcześniak G; Dziemidok P; Paprzycki PS
    Ann Agric Environ Med; 2013; 20(2):346-50. PubMed ID: 23772589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Midterm impact of sleeve gastrectomy, calibrated with a 50-Fr bougie, on weight loss, glucose homeostasis, lipid profiles, and comorbidities in morbidly obese patients.
    Ruiz-Tovar J; Oller I; Tomas A; Llavero C; Arroyo A; Calero A; Martinez-Blasco A; Calpena R
    Am Surg; 2012 Sep; 78(9):969-74. PubMed ID: 22964206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [An unusual picture of insulinoma in type-2 diabetes mellitus and morbid obesity].
    Wildbrett J; Nagel M; Theissig F; Gaertner HJ; Gromeier S; Fischer S; Hanefeld M
    Dtsch Med Wochenschr; 1999 Mar; 124(9):248-52. PubMed ID: 10102010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Swedish adjustable gastric band (SAGB) implanted laparoscopically in the treatment of morbid obesity--the first experience in Poland.
    Wylezoł M; Pardela M; Gluck M; Puzio J; Czapla J
    Med Sci Monit; 2000; 6(3):441-5. PubMed ID: 11232266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of orlistat in patients with diabetes: improvement in glycaemic control and weight loss.
    Rowe R; Cowx M; Poole C; McEwan P; Morgan C; Walker M
    Curr Med Res Opin; 2005 Nov; 21(11):1885-90. PubMed ID: 16307710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weight loss reverses secondary failure of oral hypoglycaemic agents in obese non-insulin-dependent diabetic patients independently of the duration of the disease.
    Pontiroli AE; Calderara A; Pacchioni M; Cassisa C; Pozza G
    Diabete Metab; 1993; 19(1):30-5. PubMed ID: 8504882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bariatric surgery for diabetes treatment: why should we go rapidly to surgery.
    Laville M; Disse E
    Diabetes Metab; 2009 Dec; 35(6 Pt 2):562-3. PubMed ID: 20152744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ten-year duration of type 2 diabetes as prognostic factor for remission after sleeve gastrectomy.
    Casella G; Abbatini F; Calì B; Capoccia D; Leonetti F; Basso N
    Surg Obes Relat Dis; 2011; 7(6):697-702. PubMed ID: 22000975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laparoscopic sleeve gastrectomy achieves substantial weight loss in an adolescent girl with morbid obesity.
    Till HK; Muensterer O; Keller A; Körner A; Blueher S; Merkle R; Kiess W
    Eur J Pediatr Surg; 2008 Feb; 18(1):47-9. PubMed ID: 18302070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bariatric surgery in patients with late-stage type 2 diabetes: expected beneficial effects on risk ratio and outcomes.
    Renard E
    Diabetes Metab; 2009 Dec; 35(6 Pt 2):564-8. PubMed ID: 20152745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amelioration of insulin requirement in patients undergoing duodenal bypass for reasons other than obesity implicates foregut factors in the pathophysiology of type II diabetes.
    Zervos EE; Agle SC; Warren AJ; Lang CG; Fitzgerald TL; Dar M; Rotondo MF; Pories WJ
    J Am Coll Surg; 2010 May; 210(5):564-72, 572-4. PubMed ID: 20421005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric banding for the treatment of type 2 diabetes mellitus in morbidly obese.
    Brancatisano A; Wahlroos S; Matthews S; Brancatisano R
    Surg Obes Relat Dis; 2008; 4(3):423-9. PubMed ID: 18226973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is sleeve gastrectomy as effective as gastric bypass for remission of type 2 diabetes in morbidly obese patients?
    de Gordejuela AG; Pujol Gebelli J; García NV; Alsina EF; Medayo LS; Masdevall Noguera C
    Surg Obes Relat Dis; 2011; 7(4):506-9. PubMed ID: 21411376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuro-modulation and bariatric surgery for type 2 diabetes mellitus.
    Spector D; Shikora S
    Int J Clin Pract Suppl; 2010 Feb; (166):53-8. PubMed ID: 20377665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a balanced energy and high protein formula diet (Vegestart complet®) vs. low-calorie regular diet in morbid obese patients prior to bariatric surgery (laparoscopic single anastomosis gastric bypass): a prospective, double-blind randomized study.
    Carbajo MA; Castro MJ; Kleinfinger S; Gómez-Arenas S; Ortiz-Solórzano J; Wellman R; García-Ianza C; Luque E
    Nutr Hosp; 2010; 25(6):939-48. PubMed ID: 21519764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the incretin system in the remission of type 2 diabetes following bariatric surgery.
    Mingrone G
    Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):574-9. PubMed ID: 18790374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are we closer to finding the treatment for type 2 diabetes mellitus in morbid obesity? Are the incretins the key to success?
    Frezza EE
    Obes Surg; 2004 Aug; 14(7):999-1005. PubMed ID: 15329192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.